Levonorgestrel releasing IUS [metraplant E] in the management of copper IUD related heavy painful menstrual loss

Background: the LNG-IUD was first introduced in Finland in 1990 and is currently marketed in most European countries and in the US since 2000. The Levonorgestrel IUD is approved for 5 years, but lasts up to 10 years and reduces the menstrual blood loss and pelvic infection rates

Aim of the Work: this study aimed to evaluate safety and efficacy of levonorgestrel releasing IUS [Metraplant-E] in the management of copper IUD related heavy painful menstrual loss. Among women of low socioeconomic status attended to family planning clinic at Abo-Elnomros Hospital [Abo-Elnomros is small village -Giza Government, Egypt

Patients and methods: this was a prospective cohort study and it was performed in Abo-Elnomros hospital. Women who attended to the hospital [Family planning clinic] for IUD follow up and had complications [bleeding and dysmenohrea] for which copper IUD is removed

Results: all women in the present study reported a marked reduction in MBL, which started from the first menstrual period following insertion of Metraplant -E. Bleeding was reduced further over the next months until the 6[th] month except two cases . Amenorrhea occurred in 38 cases. The difference in menstrual bleeding was highly significant [P <0.0001]. Hemoglobin level increased from a mean baseline value of 10.0 +/- 1.3 at baseline controls to a mean level of 10.5 +/- 1.2 after 6 months of Metraplant-E use. Differences in hemoglobin levels were highly significant P <0.0001

Conclusion and Recommendations: the copper IUD is the most commonly used method of reversible contraception worldwide and is used by an average of 23 percent of female contraceptive users. The copper IUD is associated with increased menstrual flow both in length of menses and in amount of blood loss. The most common reasons for the discontinuation of this method are menstrual bleeding and dysmenorrhea. Metraplant- E is effective in significantly reducing the amount of menstrual blood loss in women with heavy painful menstrual loss related to copper IUD. Strong endometrial suppression is the principal mechanism, explaining both the effect on menstrual blood loss and the contraceptive performance of the IUS. Proper treatment of the chronic endometritis prior to Metraplant-E insertion is recommended. Actively informing women about benefits, risks and common side effects of IUS appears to improve consideration and acceptance of the method

use of levonorgestrel-releasing system [metraplant-E] in the treatment of abnormal uterine bleeding

Background: Dysfunctional uterine bleeding [DUB] is one of the commonest condition for which patient seeks out medical consultation. The prevalence increases with the increase of age peaking before menopause

Objective: The aim of this work is to evaluate the effect of this new form of levonorgestrel-releasing IUD on the treatment of patients with abnormal uterine bleeding

Subjects and methods: A prospective age-specific comparative analysis of 61 peri-menopausal women presented with dysfunctional uterine bleeding who constituted the study group. They underwent hysteroscopy and endometrial sampling during an 18 months period from June 2014 to January 2016 at Ain Shams University Materity Hospital. Prior to metraplant-E application, all the patients in this study were in the age of 25-58 years old

Results: The role of Metraplant-E in the treatment of abnormal uterine bleeding [AUB] was evaluated. Sixty-one women with failed attempt[s] of medical treatment unwilling or unfit for hysterectomy were treated with Metaplant-E. Menstrual blood loss was assessed by pictoral bleeding assessment chart [PBAC], bleeding index [B.I] and total bleeding score [T.B.S/month]. The bleeding patterns in the form of the mean menstrual blood loss estimated by bleeding index and the mean menstrual loss estimated by the total bleeding score/month and PBAC decreased significantly [p = 0.001]. The quality of life scale [Likert scale] improved significantly [p = 0.001]. All 15 cases who had endometrial sampling demonstrated progestational effect on histo-pathological examination

Conclusion: Metraplant-E was found to be effective in managing dysfunctional menorrhagia on both clinical and histopathological levels

role of religious programs in the development of satellite knowledge teenagers prophet's biography

Problem: First, through the media observed intensification in the recent period on religious programs on the biography of the Prophet peace be upon him and offered elders appeared intense images on the TV screens we do not know anything about the religious point of reference. Second, confirm and permit a large number of Muslim scholars and intellectuals and media experts that religious channels-are not all good, but not all evil, but they often do more harm than good. This fact, and warn that those channels and those behind the spread of religious programs

Limits of the study: Time limits The field study was conducted in the period from 11/ 01/ 2014 until 01/ 12/ 2014. The analytical study they were conducted in the period from 2012 to 2015

Sample: The study was applied to a sample of college students [Male, Female] in the age group of age [17-18] years in Ain Shams University and 6 October University. The study population. The research community in the adolescent segment of the [male and female], in the age group of [17-18] years, and in the Ain Shams University and 6 October University

Tools: Questionnaire

Results: Came watch religious programs satellite channels, where the answer is always came by 50% of the study sample, and was chosen sometimes by 50%. came religious programs you are watching satellite TV types in the first place, Biography of the Prophet, an average of 0.76, in second place came sermons an average of 0.45, while in third place, came bezel careful Show Prophetic Biography programs on satellite channels, where the answer is always came up 55.3% of the study sample, and was chosen sometimes by 44.7%

study of balance disorders in old patients

This work studied 50 cases and 20 control patients complaining of dizziness and balance problems. The study also included 20 normal volunteer subjects to detect the 5th percentile of the used score. Each patient was diagnosed depending on history, examination and audiological and balance investigations. Semiquantitative clinical measures of equilibrium and subjective improvement were studied in patients and control groups before and after therapy. It was found that there was statistically highly significant improvement of mean score in clinical static and dynamic equilibrium after completing the vestibular rehabilitation regimen. There was a highly significant difference between the patient and the control groups in static assessment, but a insignificant difference in dynamic assessment. It was found that the static equilibrium score is more accurate than the dynamic one. There was a negative correlation between age and the degree of improvement in both static and dynamic assessment in patients and control groups. It was found that the vestibular subgroup of patients showed a statistically significant better improvement than the non-vestibular and the unknown subgroups. The benefit of vestibular rehabilitation therapy [VRT] was also found to be limited in patients with multiple medical problems. 62% of the patients' group and 15% of the control group achieved major improvement after VRT